An ephrin that was originally identified as the product of an early response gene induced by TUMOR NECROSIS FACTORS. It is linked to the CELL MEMBRANE via a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR and binds EPHA2 RECEPTOR with high affinity. During embryogenesis high levels of ephrin-A1 are expressed in LUNG; KIDNEY; SALIVARY GLANDS; and INTESTINE.
Ephrin A1 has been studied across 23 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🫘 Kidney, ✨ Skin & Hair, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 46% of studies addressing this area.
This evidence profile for Ephrin A1 is generated deterministically from 287 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.